Displaying 1281 - 1300 of 1549
System Health Providers, Inc., and Genesis Physicians Group, Inc.
System Health Providers and its parent corporation, Genesis Physicians Group, Inc., settled charges that they collectively bargained with health insurance firms to accept proposed fee schedules; discouraged members from entering into contracts directly with payers; and refused to deal with health insurance firms and other third-party payers except on collectively agreed upon terms. The order prohibits the recurrence of the alleged practices and actions.
FTC Staff Opposes Ohio Bill To Allow Physician Collective Bargaining
Statement of Â鶹´«Ã½ Trade Commission Chairman Timothy Muris on the FDA's Proposals to Improve Consumer Access To Lower-Cost Generic Drugs
Announced Actions for October 11, 2002
R.T. Welter and Associates, Inc.
Prepared Statement of the Â鶹´«Ã½ Trade Commission On Competition in the U.S. Pharmaceutical Industry
Announced Action for October 4, 2002
Workshop on Health Care and Competition Law and Policy
Announced Action for September 6, 2002
Amgen Inc. and Immunex Corporation
Amgen settled antitrust charges that its proposed $16 billion acquisition of Immunex Corporation would reduce competition and tend to create a monopoly in the biopharmaceutical markets for neutrophil (white blood cell) regeneration factors; tumor necrosis factor (TNF) inhibitors; and interleukin-1 (IL-1) inhibitors. The consent order requires the firms to sell all of Immunex's assets related to Leukine -a neutrophil regeneration factor -to Schering AG; license certain intellectual property rights to TNF inhibitors to Serono S.A.; and license certain intellectual property rights related to IL-1 inhibitors to Regeneron Pharmaceuticals Inc.
Â鶹´«Ã½ Trade Commission Announces Formation of Merger Litigation Task Force
Denver-Area Physician Practice Groups and Their Agent Agree to Settle FTC Charges of Fixing Fees
Dallas-Fort Worth-area Physicians Group Agrees to Settle
Announced Actions for August 20, 2002
Aurora Associated Primary Care Physicians, L.L.C., Richard A. Patt, M.D., Gary L. Gaede, M.D., and Marcia L. Brauchler
Physician Integrated Services of Denver, Inc., Michael J. Guese, M.D., and Marcia L. Brauchler
Resolving Anticompetitive Concerns, FTC Clears $16 Billion Acquisition of Immunex Corp. By Amgen Inc.
Administrative Law Judge Dismisses FTC Allegations of Anticompetitive Conduct by Schering-plough and Upsher-Smith
Generic Drug Entry Prior to Patent Expiration: An FTC Study
Displaying 1281 - 1300 of 1549